Login / Signup

NPP's approach toward improving rigor and transparency in clinical trials research.

Sofiya HupaloChloe J JordanTerri BowenJennifer MaharElizabeth YepezLori KunathSarah TimmKeri MartinowichWilliam A CarlezonLisa M MonteggiaTony P George
Published in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2022)
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • phase iii
  • double blind
  • study protocol